Head-to-head · WeighScore
CoreAge Rx vs telos rx
The verdict
CoreAge Rx takes it — 91.8/100 to 85.4/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | CoreAge Rx | telos rx |
|---|---|---|
| WeighScore | 91.8/100 | 85.4/100 |
| Grade | A− | B |
| Scorecard rank | #1 | #8 |
| Semaglutide | $99/mo | $99/mo injectable — the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks |
| Tirzepatide | $149/mo | $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #1 · A−
Strengths
- Flat all-in price with no month-two step-up
- Semaglutide and tirzepatide on one account
- All 50 states, LegitScript-verified
Where it loses points
- Not the cheapest sticker price
- Compounded only
- Pharmacy partner not yet publicly named
Graded #8 · B
Strengths
- Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
- Needle-free and oral GLP-1 options, not injection-only
- LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
- Low GLP-1 entry — from $49/mo microdosed on an annual plan
Where it loses points
- Everything is compounded and not FDA-approved, including the peptides
- Pricing is opaque outside GLP-1 and the lowest rates require annual lock-in
- No named clinicians and thin third-party reviews
- Several research-grade peptides carry limited clinical evidence
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.